Doctors say active monitoring, hormone therapy and newer focal treatments are reshaping care decisions for men.

Imperial College London investigators compared focal therapy with prostate removal surgery for men with prostate cancer that ...

Performed in a single session without any surgical incisions or scarring, the treatment utilizes an advanced fusion-guided system that combines magnetic resonance imaging (MRI) with precise prostate ...

As part of its Speaking Out video series, CURE talked to Dr. Brian Keith McNeil, on behalf of ZERO Prostate Cancer, about navigating treatment option in prostate cancer. Advancements in prostate ...

Today, many men must choose between life-altering prostate removal or careful long-term monitoring. The EU-funded ROBIOSPY ...

Metastatic castration-resistant prostate cancer (mCRPC) is a severe form of late-stage disease where the tumor can no longer be controlled with hormone therapy. Even in such situations, effective ...

Q: Recently, a 47-year-old asymptomatic patient had a random prostate-specific antigen (PSA) level of 5.32 ng/mL. A repeat assay the following day was 6.10. All previous PSAs over a seven-year period ...

An expert spoke with CURE® about the next steps for patients recently diagnosed with prostate cancer and the types of treatments they may receive. For patients with prostate cancer, it’s important to ...

Despite medical advances and increased awareness campaigns, many men continue postponing essential prostate treatment. Health care providers identify several key factors contributing to these ...

For the first time ever, NTNU researchers have identified new characteristics of aggressive prostate cancer. The research lays a foundation for the possibility that aggressive prostate cancer can ...

Prostate involvement was first reported in IgG4-RD approximately 2 decades ago and comprises only 9.6% of cases. A male patient in his 7os presented with isolated prostatitis associated with ...